v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2025       144,444,000 19,469,000        
Stockholders' Equity, beginning balance at Jan. 31, 2025 $ 821,306     $ 0 $ 0 $ 1,952,031 $ (1,167,614) $ (8,508) $ 45,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       622,000 (622,000)        
Issuance of common stock related to vested exercised stock options (in shares)         357,000        
Issuance of common stock related to vested exercised stock options 3,338                
Common stock repurchased/Repurchases, net of early exercised stock options (in shares)         (1,000)        
Issuance of common stock related to RSUs and PSUs vested (in shares)       787,000          
Charitable donation of common stock (in shares)   40,889   41,000          
Charitable donation of common stock 1,739 $ 1,700       1,739      
Vesting of early exercised stock options 38         38      
Stock-based compensation expense 55,827         55,984     (157)
Change in noncontrolling interest ownership 0         98     (98)
Other comprehensive income (loss) 6,607             7,049 (442)
Net loss (36,258)           (35,875)   (383)
Stockholders' Equity, ending balance (in shares) at Apr. 30, 2025       145,894,000 19,203,000        
Stockholders' Equity, ending balance at Apr. 30, 2025 852,597     $ 0 $ 0 2,013,228 (1,203,489) (1,459) 44,317
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2026   153,336,000 16,732,000 153,336,000 16,732,000        
Stockholders' Equity, beginning balance at Jan. 31, 2026 $ 1,036,248 [1]     $ 0 $ 0 2,207,361 (1,223,570) 6,877 45,580
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       660,000 (660,000)        
Issuance of common stock related to vested exercised stock options (in shares) 178,000       178,000        
Issuance of common stock related to vested exercised stock options $ 2,373         2,373      
Common stock repurchased/Repurchases, net of early exercised stock options (in shares)       (2,379,000)          
Common stock repurchased (50,313)         (50,313)      
Issuance of common stock related to RSUs and PSUs vested (in shares)       963,000          
Common stock withheld related to net share settlement of equity awards (in shares)       (7,000)          
Common stock withheld related to net share settlement of equity awards (160)         (160)      
Charitable donation of common stock (in shares)   40,889   41,000          
Charitable donation of common stock 821 $ 800       821      
Stock-based compensation expense 50,061         49,165     896
Other comprehensive income (loss) (2,065)             (2,378) 313
Net loss (5,579)           (4,972)   (607)
Stockholders' Equity, ending balance (in shares) at Apr. 30, 2026   152,614,000 16,250,000 152,614,000 16,250,000        
Stockholders' Equity, ending balance at Apr. 30, 2026 $ 1,031,386 [1]     $ 0 $ 0 $ 2,209,247 $ (1,228,542) $ 4,499 $ 46,182
[1]
(1) As of April 30, 2026 and January 31, 2026, the condensed consolidated balance sheets include assets of the condensed consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $40.6 million and $41.0 million, respectively, and liabilities of $6.6 million and $7.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 10. Joint Venture” for further discussion.